Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1000 of 2051 entries
View as:

Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)

Phase: N/A Priority: Normal
NCT ID: NCT01982630 Org: User:
Start: 11/07/13 End: 10/03/14 Due: 10/03/15

Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00040534 Org: User:
Start: 01/31/01 End: 07/31/04 Due: 07/31/05

Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00673062 Org: User:
Start: 05/31/08 End: 07/31/08 Due: 07/31/09

The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002443 Org: User:
Start: - End: 01/31/96 Due: 01/31/97

MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00518739 Org: User:
Start: 02/28/07 End: 12/31/08 Due: 12/31/09

A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)

Phase: N/A Priority: Normal
NCT ID: NCT04490499 Org: User:
Start: 09/02/20 End: 12/29/20 Due: 12/29/21

Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass

Phase: N/A Priority: Normal
NCT ID: NCT00316212 Org: User:
Start: 04/30/06 End: - Due: -

A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064)

Phase: N/A Priority: Normal
NCT ID: NCT00816712 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09

Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT00425165 Org: User:
Start: 08/31/07 End: 05/31/08 Due: 05/31/09

A Single Rising Dose Study of MK-8150 (MK-8150-001)

Phase: N/A Priority: Normal
NCT ID: NCT01590810 Org: User:
Start: 05/07/12 End: 02/05/13 Due: 02/05/14

A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)

Phase: N/A Priority: Normal
NCT ID: NCT01632345 Org: User:
Start: 10/12/12 End: 03/21/16 Due: 03/21/17

A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)

Phase: N/A Priority: Normal
NCT ID: NCT00977288 Org: User:
Start: 09/30/09 End: 04/30/14 Due: 04/30/15

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

Phase: N/A Priority: Normal
NCT ID: NCT00941603 Org: User:
Start: 06/29/09 End: 02/22/10 Due: 02/22/11

MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)

Phase: N/A Priority: Normal
NCT ID: NCT00797667 Org: User:
Start: 11/12/08 End: 05/20/09 Due: 05/20/10

A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001)

Phase: N/A Priority: Normal
NCT ID: NCT01358331 Org: User:
Start: 11/04/11 End: 05/20/14 Due: 05/20/15

A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007)

Phase: N/A Priority: Normal
NCT ID: NCT00907738 Org: User:
Start: 08/31/05 End: 06/30/10 Due: 06/30/11

A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)

Phase: N/A Priority: Normal
NCT ID: NCT01641926 Org: User:
Start: 11/26/12 End: 01/21/16 Due: 01/21/17

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

Phase: N/A Priority: Normal
NCT ID: NCT00002208 Org: User:
Start: - End: - Due: -

Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)

Phase: N/A Priority: Normal
NCT ID: NCT01373450 Org: User:
Start: 06/30/11 End: 07/31/11 Due: 07/31/12

Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

Phase: N/A Priority: Normal
NCT ID: NCT00709059 Org: User:
Start: 12/31/04 End: 12/31/09 Due: 12/31/10

Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

Phase: N/A Priority: Normal
NCT ID: NCT01736683 Org: User:
Start: 11/28/12 End: 04/30/18 Due: 04/30/19

A Multiple Dose Titration Study of MK-8892 in Participants With Pulmonary Hypertension and Left Heart Disease (MK-8892-007)

Phase: N/A Priority: Normal
NCT ID: NCT02078557 Org: User:
Start: 05/09/14 End: 09/10/14 Due: 09/10/15

Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)

Phase: N/A Priority: Normal
NCT ID: NCT00486720 Org: User:
Start: 06/30/07 End: 07/31/09 Due: 07/31/10

Bioavailability of Doravirine (MK-1439) Experimental Nano Formulations in Healthy Adults (MK-1439-046)

Phase: N/A Priority: Normal
NCT ID: NCT02549040 Org: User:
Start: 09/21/15 End: 12/24/15 Due: 12/24/16

Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00705471 Org: User:
Start: 04/30/05 End: 09/30/07 Due: 09/30/08